These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10874473

  • 1. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
    Luo D, Cheng SC, Xie H, Xie Y.
    Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
    [Abstract] [Full Text] [Related]

  • 2. Expression of Bcl-2 family proteins during chemotherapeutic agents-induced apoptosis in the hepatoblastoma HepG2 cell line.
    Luo D, Cheng SC, Xie Y.
    Br J Biomed Sci; 1999; 56(2):114-22. PubMed ID: 10695052
    [Abstract] [Full Text] [Related]

  • 3. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
    Zhang J, Cheng C, He CL, Zhou YJ, Cao Y.
    Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J, Kirchner B, Eicher C, Warmann SW, Seitz G, Fuchs J, Armeanu-Ebinger S.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1089-95. PubMed ID: 20680965
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 gene silencing in pediatric epithelial liver tumors.
    Warmann SW, Frank H, Heitmann H, Ruck P, Herberts T, Seitz G, Fuchs J.
    J Surg Res; 2008 Jan 01; 144(1):43-8. PubMed ID: 17574594
    [Abstract] [Full Text] [Related]

  • 6. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR, Fletcher B, Page C, Hu C, Nunez G, Baker V.
    Gynecol Oncol; 1998 Sep 01; 70(3):398-403. PubMed ID: 9790794
    [Abstract] [Full Text] [Related]

  • 7. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.
    Oncogene; 2002 Sep 19; 21(42):6510-9. PubMed ID: 12226754
    [Abstract] [Full Text] [Related]

  • 8. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 19; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E, Lee KY.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):771-9. PubMed ID: 14975768
    [Abstract] [Full Text] [Related]

  • 10. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2005 Apr 12; 26(4):713-23. PubMed ID: 15661804
    [Abstract] [Full Text] [Related]

  • 11. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
    Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T.
    Cancer Res; 1998 Aug 01; 58(15):3331-8. PubMed ID: 9699663
    [Abstract] [Full Text] [Related]

  • 12. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
    Tirado OM, Mateo-Lozano S, Notario V.
    Oncogene; 2005 May 05; 24(20):3348-57. PubMed ID: 15782132
    [Abstract] [Full Text] [Related]

  • 13. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
    Kawakami K, Tsukuda M, Mizuno H, Nishimura G, Ishii A, Hamajima K.
    Anticancer Res; 1999 May 05; 19(5B):3927-32. PubMed ID: 10628333
    [Abstract] [Full Text] [Related]

  • 14. Taxol induced Bcl-2 protein phosphorylation in human hepatocellular carcinoma QGY-7703 cell line.
    Cheng SC, Luo D, Xie Y.
    Cell Biol Int; 2001 May 05; 25(3):261-5. PubMed ID: 11352500
    [Abstract] [Full Text] [Related]

  • 15. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M, Louis MH, Dutoit S, Brotin E, Lincet H, Duigou F, Staedel C, Gauduchon P, Poulain L.
    Gynecol Oncol; 2007 Apr 05; 105(1):31-44. PubMed ID: 17275076
    [Abstract] [Full Text] [Related]

  • 16. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
    Fernández Y, España L, Mañas S, Fabra A, Sierra A.
    Cell Death Differ; 2000 Apr 05; 7(4):350-9. PubMed ID: 10773819
    [Abstract] [Full Text] [Related]

  • 17. Expression and role of Bcl-xL in human hepatocellular carcinomas.
    Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H.
    Hepatology; 2001 Jul 05; 34(1):55-61. PubMed ID: 11431734
    [Abstract] [Full Text] [Related]

  • 18. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M, Raffo AJ, Benimetskaya L, Shames D, Stein CA.
    Cancer Res; 2002 Apr 01; 62(7):2175-83. PubMed ID: 11929841
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 01; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 20. Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL.
    Giuliano M, Bellavia G, Lauricella M, D'Anneo A, Vassallo B, Vento R, Tesoriere G.
    Int J Mol Med; 2004 Apr 01; 13(4):565-71. PubMed ID: 15010857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.